086 Safety and efficacy of filgotinib in a phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic disease modifying anti-rheumatic drugs. (12th April 2019) - Walker, David; Genovese, Mark C; Kalunian, Kenneth; Gottenberg, Jacques-Eric; de Vlam, Kurt; Mozaffarian, Neelufar; Bartok, Beatrix; Matzkies, Franziska; Gao, Jie; Guo, Ying; Tasset, Chantal; Sundy, John S; et al.